Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0014025 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Billy Ogwel und 35 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya. Hauptthemen laut MEDLINE: Biomarkers, Feces, Dysentery, Bacillary, Diarrhea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation, Bill and Melinda Gates Foundation I.
Abstract (Originalsprache)
Background
Current syndromic guidelines for diarrhea treatment miss watery Shigella cases, leading to undertreatment of children who may benefit. Incorporating fecal inflammatory biomarkers into diagnosis may improve case identification.
Methods
We conducted an ancillary analysis using samples from six sites (The Gambia, Kenya, Malawi, Bangladesh, Pakistan, and Peru) from the Enterics for Global Health (EFGH)- Shigella surveillance study, a facility-based hybrid study of children aged 6–35 months with diarrhea. Four fecal biomarkers were quantified by enzyme-linked immunosorbent assays at enrollment: myeloperoxidase, calprotectin, neutrophil gelatinase-associated lipocalin (lipocalin-2), and hemoglobin. An ensemble model with leave-one-site-out cross-validation was used to predict watery shigellosis, incorporating biomarkers and nine clinical and socio-economic predictors. We compared the predictive performance of the algorithm using: a) all predictors (including biomarkers); b) all non-biomarker predictors; c) all predictors (with selected biomarkers).
Results
Between June 2022 and August 2024, a total of 4,191/9,476 (44.2%) children presented with watery diarrhea (non-bloody) and had their whole stool tested for the biomarkers and 4,083 stool samples or rectal swabs were tested by qPCR; 735 (18.0%) had Shigella- attributable diarrhea by qPCR. The full model incorporating all 13 predictors achieved an area under the curve (AUC) of 0.75 [95% CI: 0.67–0.78], with a sensitivity of 0.67 and specificity of 0.75. Excluding biomarkers reduced model performance by 8% (AUC 0.67, 95% CI: 0.61-0.70). Adding hemoglobin alone improved the model’s discriminatory ability by 7%, while further adding myeloperoxidase had marginal contribution (1%), and lipocalin-2 (0%) and calprotectin none (0%).
Conclusion
Fecal hemoglobin substantially improved prediction scores for watery shigellosis. Consequently, implementation of point-of-care assays for hemoglobin could improve clinical diagnosis in these settings and inform appropriate antibiotic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
- Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b), Dhaka, Bangladesh.
- Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
- Malawi Liverpool Wellcome Programme, Blantyre, Malawi.
- Department of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
ORCID-Profile: Billy Ogwel
Förderung
- Bill and Melinda Gates Foundation
- Bill and Melinda Gates Foundation I
Zitieren
APA
Ogwel, B., Khanam, F., Badji, H., Charles, M., Qureshi, S., Horne, B., Brennhofer, S. A., Platts-Mills, J. A., Sears, K., Tennant, S., Kim, S., Omore, R., Awuor, A. O., Okonji, C., Iqbal, J., Ahmed, N., Hussain, Z., Qadri, F., Raz, S. M. A. A., …, & Rogawski McQuade, E. T. (2026). Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014025
Vancouver
Ogwel B, Khanam F, Badji H, Charles M, Qureshi S, Horne B, et al. Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014025
BibTeX
@article{Ogwel2026,
author = {Ogwel, Billy and Khanam, Farhana and Badji, Henry and Charles, Mary and Qureshi, Sonia and Horne, Bri'Anna and Brennhofer, Stephanie A and Platts-Mills, James A and Sears, Khandra and Tennant, Sharon and Kim, Sara and Omore, Richard and Awuor, Alex O and Okonji, Caleb and Iqbal, Junaid and Ahmed, Naveed and Hussain, Zarfishan and Qadri, Firdausi and Raz, S M Azadul Alam and Bhuiyan, Elias Shawon and Yori, Pablo Penataro and Olortegui, Maribel Paredes and Kosek, Margaret N and Jallow, Samba Juma and Ceesay, Bubacarr E and Conteh, Bakary and Nyirenda, Atusaye K and Munthali, Vitumbiko and Lefu, Clement and Bhuiyan, Taufiqur Rahman and Munga, Stephen and Hossain, M Jahangir and Cornick, Jennifer and Qamar, Farah Naz and Benkeser, David and Rogawski McQuade, Elizabeth T},
title = {Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0014025}
}
EUVIMED